Corporate Banner
Satellite Banner
Biomolecular Screening
Scientific Community
Become a Member | Sign in
Home>News>This Article

Dolomite Expertise Brings Microfluidic Product to Market

Published: Monday, June 24, 2013
Last Updated: Monday, June 24, 2013
Bookmark and Share
Fledgling spin-out company Drop-Tech has turned to microfluidics specialist Dolomite for its product development and fabrication skills.

Dolomite to help productize the advanced and innovative Robo¬Drop™ technology into the Mitos Dropix, a droplet-on-demand sampler that is set to make it easy to produce extremely miniaturized droplet compartments with excellent control over their contents.

Access to this new high-throughput screening format will prove invaluable in basic research, drug discovery and diagnostics applications.

The collaboration began when Drop-Tech entered – and won – Dolomite’s Productizing Science® Competition, sparking discussions and exchanges of ideas between the two development teams. Liisa van Vliet, a Post-doctoral Research Associate at the University of Cambridge and Managing Director of Drop-Tech, explained: “Drop-Tech was formed from an academic collaboration between Imperial College London and the University of Cambridge. In a university environment, finding the time to convert an invention into a product is often difficult, so we welcomed Dolomite’s offer to accelerate product development, fast-tracking the transition from idea to market; Dolomite knows and understands microfluidic droplet technologies and has the engineering expertise to productize the instrument. Drop¬Tech’s Technical Director Fabrice Gielen and I met with Dolomite’s product development team to discuss the internal workings of the instrument. Together, we were able to bounce ideas back and forth to incorporate improvements and determine a list of specifications.”

The Mitos Dropix sampler allows the creation of nanoliter droplet sequences from up to 24 different samples, with precise control over droplet content and size, as well as the spacing between droplets. It can be used as an add-on for conventional microfluidic chips, delivering droplets for merging, further miniaturization, dilution or any other droplet manipulation, and will also be an invaluable tool to use in conjunction with other analytical and liquid handling systems. The first batch of instruments will be with beta testers by summer 2013, and further collaboration is planned to develop droplet analysis capabilities on upcoming versions of the instrument.

Liisa concluded: “This has been a great start to our collaboration. From the beginning, our aim was to make microfluidics easier and, with Dolomite’s help, we will be able to provide scientists with an easy-to-use instrument that can dispense controlled, user-defined sequences of nanoliter droplets for a range of diverse applications.” Drop-Tech and Dolomite are already looking forward to additional Productizing Science collaborations in the future.

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,600+ scientific posters on ePosters
  • More than 3,800+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Scientific News
Enzyme Malfunction May be Why Binge Drinking Can Lead to Alcoholism
A new study in mice shows that restoring the synthesis of a key brain chemical tied to inhibiting addictive behavior may help prevent alcohol cravings following binge drinking.
Cell's Waste Disposal System Regulates Body Clock Proteins
New way to identify interacting proteins could identify potential drug targets.
Compound Doubles Up On Cancer Detection
Researchers have found that tagging a pair of markers found almost exclusively on a common brain cancer yields a cancer signal that is both more obvious and more specific to cancer.
Promising Drug Candidate to Treat Chronic Itch
In a new study, scientists from the Florida campus of The Scripps Research Institute (TSRI) describe a class of compounds with the potential to stop chronic itch without the adverse side effects normally associated with medicating the condition.
Are Changes to Current Colorectal Cancer Screening Guidelines Required?
Editorial suggests more research is needed to pinpoint age to end aggressive screening.
Assessing Cancer Patient Survival and Drug Sensitivity
RNA editing events another way to investigate biomarkers and therapy targets.
New Molecular Marker for Killer Cells
Cell marker enables prognosis about the course of infections.
Potential Target for Treatment of Autism
Grant of $2.4 million will support further research.
Sniffing Out Cancer
Scientists have been exploring new ways to “smell” signs of cancer by analyzing what’s in patients’ breath.
Inroads Against Leukaemia
Potential for halting disease in molecule isolated from sea sponges.

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,600+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,800+ scientific videos